In the News | Citizen Health Press Highlights

By leveraging AI, Citizen Health aims to reduce therapy advancement timelines and provide personalized health insights for rare disease patients.

The funding round was led by Transformation Capital, with participation from Wavemaker 360 and prominent angel investors. This fundraise is further strengthened by a strategic program investment and partnership with the Chan Zuckerberg Initiative (CZI).

Citizen Health emerged from stealth on Tuesday, announcing $14.5 million in seed funding and a partnership with the Chan Zuckerberg Initiative (CZI) to drive rare disease drug development.

A Palo Alto health care startup previously known as Ciitizen has relaunched as Citizen Health after being spun out of Invitae last year.

That new entity has now officially launched, and the overarching goal has remained the same: to empower patients with access to their complete health history.

Citizen Health takes a sharper focus on rare diseases and is co-founded by Ciitizen founder Farid Vij and rare disease patient advocate Nasha Fitter.

Forbes gathered some of the world’s most exceptional CIOs across industries to better understand how they are navigating the choppy waters and positioning their organizations for success.

“Until these networks establish standards for, and open up to, data-sharing permitted by HIPAA but that isn’t [for] treatment, we will see entities trying to morph themselves into a treatment use case in order to get the records they need,” said Deven McGraw, a former high-ranking HHS health privacy official in the Obama and Trump administrations and now chief regulatory and privacy officer at Citizen Health.

Farid Vij, CEO and founder of Citizen Health, said the relationships between sponsors, patients, researchers and clinicians need consistent collaboration.